105544-36-3

Basic information

• Product Name: 7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2(3H)-ONE
• Synonyms: 7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2(3H)-ONE;7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2-ONE;7-broMo-1H,2H,3H-pyrido[2,3-b][1,4]oxazin-2-one;:1H-Pyrido[2,3-b][1,4]oxazin-2(3H)-one,7-broMo
• CAS NO: 105544-36-3
• Molecular Formula: C₇H₅BrN₂O₂
• Molecular Weight: 229.0308
• Mol File: 105544-36-3.mol
• Article Data: 8

Chemical Properties

• Melting Point: 247-251 °C(Solv: ethanol (64-17-5))
• Boiling Point: 398.8 °C at 760 mmHg
• Flash Point: 195 °C
• Appearance: /
• Density: 1.772 g/cm³
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 10.67±0.20(Predicted)
• CAS DataBase Reference: 7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2(3H)-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2(3H)-ONE(105544-36-3)
• EPA Substance Registry System: 7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2(3H)-ONE(105544-36-3)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 105544-36-3(Hazardous Substances Data)

Usage

General Description

7-Bromo-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one is a chemical compound with a molecular formula C6H3BrN2O2. It is a heterocyclic compound with a pyridine ring fused to an oxazine ring, and a bromine atom attached to the pyridine ring. 7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2(3H)-ONE is used in the pharmaceutical and agrochemical industry as a building block for the synthesis of various organic compounds. It has also been studied for its potential biological activities, particularly as an antiviral and antibacterial agent. The unique structure of 7-Bromo-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one makes it a valuable intermediate for the synthesis of diverse chemical products.

Upstream product

• 227963-72-6 methyl 2-((5-bromo-3-nitropyridin-2-yl)oxy)acetate 
• 67443-38-3 5-bromo-2-chloro-3-nitropyridine 
• 105544-30-7 ethyl-2-((5-bromo-3-nitropyridin-2-yl)oxy)acetate 

Downstream Products

• 1349831-01-1 7-((2R,5R)-2-methyl-5-phenylmorpholino)-1H-pyrido[2,3-b]-[1,4]oxazin-2(3H)-one 
• 1313439-65-4 6-(4-(1-aminocyclobutyl)phenyl)-7-(cyclopropylmethyl)-1-methyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one 
• 1313441-62-1 tert-butyl (1-(4-(7-(cyclopropylmethyl)-1-methyl-2-oxo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-6-yl)phenyl)cyclobutyl)carbamate 
• 1313441-61-0 tert-butyl (1-(4-(7-allyl-1-methyl-2-oxo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-6-yl)phenyl)cyclobutyl)carbamate 
• 1313441-60-9 tert-butyl (1-(4-(7-(4-fluorophenyl)-1-methyl-2-oxo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-6-yl)phenyl)cyclobutyl)carbamate 
• 1313439-58-5 6-(4-(1-aminocyclobutyl)phenyl)-1-methyl-7-(thiophen-2-yl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one 
• 1313441-52-9 tert-butyl (1-(4-(1-methyl-2-oxo-7-(thiophen-2-yl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-6-yl)phenyl)cyclobutyl)carbamate 
• 1313439-57-4 6-(4-(1-aminocyclobutyl)phenyl)-1-methyl-7-(thiophen-3-yl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one 
• 1313441-51-8 tert-butyl (1-(4-(1-methyl-2-oxo-7-(thiophen-3-yl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-6-yl)phenyl)cyclobutyl)carbamate 
• 1313439-56-3 6-(4-(1-aminocyclobutyl)phenyl)-1-methyl-7-(pyridin-3-yl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one 
• 1313441-50-7 tert-butyl (1-(4-(1-methyl-2-oxo-7-(pyridin-3-yl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-6-yl)phenyl)cyclobutyl)carbamate 
• 1313441-49-4 tert-butyl (1-(4-(7-bromo-1-methyl-2-oxo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-6-yl)phenyl)cyclobutyl)carbamate 
• 1198154-03-8 7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one 
• 1186658-27-4 7-bromo-1-methyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one 

Relevant articles and documents

CHROMENOPYRIMIDINE DERIVATIVES AS PHOSPHATIDYLINSITOL PHOSPHATE KINASE INHIBITORS

The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula: where A1, A2, G, R1, R2, R3, R4, and W are described herein.

HETEROARYL COMPOUNDS AS INHIBITORS OF NECROSIS, COMPOSITION AND METHOD USING THE SAME

The present disclosure provides heteroaryl compounds of Formula (I), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to necrosis. Formula (I) is shown below:

HETEROCYCLIC DERIVATIVES

The present invention relates to heterocyclic derivatives, and more particularly, to novel heterocyclic derivatives useful for the preparation of medicaments for treating diseases related to uric acid.